Q32 Bio (QTTB) EBT Margin (QoQ) (2018 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 272,288.00 |
| Sep 30, 2023 | -57,008.00 |
| Jun 30, 2023 | 5,085.00 |
| Mar 31, 2023 | 388,754.00 |
| Dec 31, 2022 | -18,030.00 |
| Sep 30, 2022 | -46,883.00 |
| Jun 30, 2022 | -1.51 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Dec 31, 2021 | -236,224.00 |
| Sep 30, 2021 | -43,056.00 |
| Jun 30, 2021 | -139,094.00 |
| Mar 31, 2021 | 303,624.00 |
| Dec 31, 2020 | 193,929.00 |
| Sep 30, 2020 | 125,362.00 |
| Jun 30, 2020 | -22,413.00 |
| Mar 31, 2020 | -171,613.00 |
| Dec 31, 2019 | 242,560.00 |
| Sep 30, 2019 | -1,661.00 |
| Jun 30, 2019 | 213,254.00 |
| Mar 31, 2019 | -726,334.00 |
| Dec 31, 2018 | -68,759.00 |
| Sep 30, 2018 | 761.00 |
| Jun 30, 2018 | 1,421.00 |